Skip to main content
Log in

Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Because of the striking similarity of the clinical manifestations produced by use of the drug reserpine and seen in patients with the chronic fatigue syndrome (CFS), we theorized that CFS was a disorder of reduced central sympathetic drive. Because of the pharmacology of control of this central sympathetic system, we further postulated that CFS symptoms would respond quickly to low dose treatment with a monamine oxidase inhibitor. To test these hypotheses, we designed a randomized, double blind placebo controlled study using phenelzine. No patient in the trial had a diagnosis of lifetime or current psychiatric disorder and none had depressed mood in the range of clinically depressed patients on a paper and pencil test of depression. Patients in the placebo group received placebo for 6 weeks while those in the drug treatment group were treated in three 2-week segments — placebo, 15 mg phenelzine every other day, and then 15 mg daily. This treatment regimen produced a significant pattern of improvement compared to worsening in 20 self report vehicles of CFS symptoms, illness severity, mood or functional status. Thus the data support our hypothesis of reduced sympathetic drive, although an alternative hypothesis of pain alleviation is also possible. The study design also allowed us to evaluate patients for a placebo effect: no evidence for this was found, suggesting that CFS is not an illness due to patients' being overly suggestible.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alfonso GR, Chase GD, Cribson MR, Granberg B, Harvey SC, King RE, Martin AN, Medwick T, Swinyard EA, Zink GL (eds) (1985) Remington's pharmaceutical sciences, 17th edn. Mack Publishing, Easton, Pa, pp 908–1097

    Google Scholar 

  • Agarwal SK, Calaresu FR (1993) Supramedullary inputs to cardiovascular neurons of rostral ventrolateral medulla in rats. Am J Physiol 265:111–116

    Google Scholar 

  • Efron B, Tibshirani T (1993) Permutation tests. In: An introduction to the bootstrap. Chapman & Hall, New York, pp 202–219

    Google Scholar 

  • Friedberg F, Krupp LB (1994) A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis 18 [Suppl 1]:S105-S110

    PubMed  Google Scholar 

  • Fukuda K, Straus SE, Hickie I, Sharpe MC, Komaroff A, Schluederberg A, Jones JF, Lloyd AR, Wessely S, Gantz NG, Holmes GP, Steele L, Reyes M, Abbey S, Rest J, Jolson H, Peterson DL, Vercoulen JHMM, Tirelli U, Evengard B, Natelson BH, Reeves WC (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med 121:953–959

    PubMed  Google Scholar 

  • Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE et al. (1988) Chronic fatigue syndrome: a working case definition. Ann Int Med 108:387–389

    PubMed  Google Scholar 

  • Jette AM, Davies AR, Clearly PD, Calkins DR, Rubenstein LV, Find A, Kosecoff J, Young RT, Brook RH, Delbanco TL (1988) The functional status questionnaire:reliability and validity when used in primary care. J Gen Int Med 1:143–149

    Google Scholar 

  • Komaroff AL, Buchwald D (1991) Symptoms and signs of chronic fatigue syndrome. Rev Infec Dis 13:S8-S11

    Google Scholar 

  • Lane TJ, Manu P, Matthews DA (1991) Depression and somatization in the chronic fatigue syndrome. Am J Med 91:335–344

    Article  PubMed  Google Scholar 

  • Marcus S, Robins LN, Bucholz K (1990) Quick Diagnostic Interview Schedule 3R version 1. Washington University School of Medicine, St. Louis, mo.

    Google Scholar 

  • McNair DM, Lorr M, Droppleman LF (1971) Profile of mood states:manual. Educational and Industrial Testing Service, San Diego

    Google Scholar 

  • Melia KR, Rasmussen K, Terwilliger RZ, Haycock JW, Nestler EJ, Duman RS (1992) Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments. J Neurochem 58:494–502

    PubMed  Google Scholar 

  • Miyawaki T, Kawamura H, Hara K, Suzuki K, Usui W, Yasugi T (1993) Differential regional hemodynamic changes produced by thel-glutamate stimulation of the locus coeruleus. Brain Res 600:50–62

    Article  Google Scholar 

  • Natelson BH, Johnson SK, DeLuca J, Sisto S, Ellis SP, Hill N, Bergen MT (1995) Reducing heterogeneity in the chronic fatigue syndrome:a comparison with depression and multiple sclerosis. Clin Infect Dis 21:1204–1210

    PubMed  Google Scholar 

  • Onghena P, Van Houdenhove B (1992) Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 49:205–219

    Article  PubMed  Google Scholar 

  • Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK (1993) A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatr Clin Neurosci 5:200–205

    Google Scholar 

  • Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Measurement 1:385–401

    Google Scholar 

  • Rickels K, Chung HR, Csanalosi IB, Hurowitz AM, London J, Wiseman K, Kaplan M, Amsterdam JD (1987) Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Arch Gen Psychiatry 44:862–866

    PubMed  Google Scholar 

  • Schulberg H, Saul M, McClelland M, Ganguli M, Christy W, Frank R (1985) Assessment of depression in primary medical and psychiatric practices. Arch Gen Psychiatry 42:1164–1170

    PubMed  Google Scholar 

  • Shorter E (1992) From paralysis to fatigue—a history of psychosomatic illness in the modern era. Free Press, New York, N.Y.

    Google Scholar 

  • Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, Hallahan C, Henle W (1988) Acyclovir treatment of the chronic fatigue syndrome. N Engl J Med 319:1692–1698

    PubMed  Google Scholar 

  • USP-DI (1990) United States pharmacopeial drug information for health care professionals. US Pharmacopeial Convention, Rockville, MD, pp 2374–2377

    Google Scholar 

  • Valentino RJ, Curtis AL (1991) Antidepressant interactions with corticotropin releasing factor in the noradrenergic nucleus locus coeruleus. Psychopharmamol Bull 27:263–269

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Natelson, B.H., Pareja, J., Policastro, T. et al. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology 124, 226–230 (1996). https://doi.org/10.1007/BF02246661

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246661

Key words

Navigation